Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice

Annals of Pharmacotherapy

Volumn 44, Issue 1, 2010, Pages 88-96

  Robinson, J Daniel ^a   Segal, Richard ^a   Lopez, Larry M ^a   Doty, Randell E ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Blood pressure; Community pharmacists; Hypertension; Medication adherence; Outcomes

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; DIASTOLIC BLOOD PRESSURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PATIENT COUNSELING; PHARMACEUTICAL CARE; PHARMACIST; PHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE;

ANTIHYPERTENSIVE AGENTS; COMMUNITY PHARMACY SERVICES; DATA COLLECTION; HUMANS; HYPERTENSION; PHARMACEUTICAL SERVICES; QUALITY OF LIFE;

EID: 74549193410     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L289     Document Type: Article

References (26)

1. Scolaro KL, Stamm PL, Lloyd KB. Devices for ambulatory and home monitoring of blood pressure, lipids, coagulation, and weight management, part 1. Am J Health Syst Pharm 2005;62:1802-12. DOI 10.2146/ajhp040346.p1
2. Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998;339:1957-63. DOI 10.1056/NEJM199812313392701
3. McKenney JM, Slining JM, Henderson HR, Devins D, Barr M. Hypertensive patients who received pharmacist counseling were more compliant with their treatment, and achieved better blood pressure control, than a control group. Circulation 1973;48:1104-11.
4. Park JJ, Kelly P, Carter BL, Burgess PP. Comprehensive pharmaceutical care in the chain setting. J Am Pharm Assoc (Wash) 1996;NS36:443-51.
5. Okamoto MP, Nakahiro RK. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic. Pharmacotherapy 2001;21:1337-44. DOI 10.1592/phco.21.17.1337.34424
6. Borenstein JE, Graber G, Saltiel E, et al. Physician-pharmacist co-management of hypertension: a randomized comparative trial. Pharmacotherapy 2003;23:209-16.
7. Grainger-Rousseau TJ, Miracles MA, Hepler CD, Segal R, Doty RE, Ben-Joseph R. Therapeutic outcomes monitoring: application of pharmaceutical care guidelines to community pharmacy. J Am Pharm Assoc 1997;NS37:647-61.
8. McLean DL, McAlister FA, Johnson JA, et al. Randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention pharmacists-hypertension (SCRIP-HTN). Arch Intern Med. 2008;168:2355-61. DOI 10.1001/archinte.168.21.2355
9. Nau DP, Grainger-Rousseau TJ, Doty RE, Hepler CD, Ried LD, Segal R. Preparing pharmacists for pharmaceutical care. J Am Pharm Assoc 1998;38:644-5.
10. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. JAMA 2003;289:2560-72. DOI 10.1001/jama.289.19.2560
11. Mallion JM, Baguet JP, Siche JP, Tremil F, De Gaudemaris R. Clinical value of ambulatory blood pressure monitoring. J Hypertens 1999;17:585-95. http://dx.doi.org/10.1097/01.hjh.0000249720.05006.d5
12. Rosner BA, Appel LJ, Raczynski JM, et al. A comparison of two automated monitors in the measurement of blood pressure reactivity. Trials of Hypertension Prevention Collaborative Research Group. Ann Epidemiol 1990;1:57-69.
13. Martinelli V, Fusar-Poli P, Emanuele E, et al. Getting old with a new heart: impact of age on depression and quality of life in long-term heart transplant recipients. J Heart Lung Transplant 2007;26:544-8. http://dx.doi.org/10.1016/j.healun.2007.01.023
14. Gourley GA, Portner TS, Gourley DR, et al. Humanistic outcomes in the hypertension and COPD arms of a multi-center outcomes study. J Am Pharm Assoc (Wash) 1998;38:586-97.
15. Ware JE. The SF-36 Health Survey. In: Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia: Lippincott-Raven Publishers, 1990:337-45.
16. Erickson SR, Slaughter R, Halapy H. Pharmacists' ability to influence outcomes of hypertension therapy. Pharmacotherapy 1997;17:140-7.
17. Carter BL, Barnette DJ, Chrischilles E, Mazzotti GJ, Asali ZJ. Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting. Pharmacotherapy 1997;17:1274-85.
18. Chabot I, Moisan J, Gregoire JP, Milot A. Pharmacist intervention program for control of hypertension. Ann Pharmacother 2003;37:1186-93. DOI 10.1345/aph.1C267
19. Earle KA, Taylor P, Wyatt S, Burnett S, Ray J. A physician-pharmacist model for the surveillance blood pressure in the community: a feasibility study. J Hum Hypertens 2001;15:529-33. DOI 10.1038/sj.jhh.1001220
20. Zillich AJ, Sutherland JM, Kumbera PA, Carter BL. Hypertension Outcomes Through Blood Pressure Monitoring and Evaluation by Pharmacists (HOME Study). J Gen Internal Med 2005;20:1091-6. DOI 10.1111/j.1525-1497.2005.0226.x
21. McConnell KJ, Zadvorny EB, Hardy AM, Delate T, Rasmussen JR, Merenich JA. Coronary artery disease and hypertension: outcomes of a pharmacist-managed blood pressure program. Pharmacotherapy 2006; 26:1333-41. DOI 10.1592/phco.26.9.1333
22. Carter BL, Zillich AJ. Pharmaceutical care services for patients with hypertension. Ann Pharmacother 2003;37:1335-7. DOI 10.1345/aph.1D094
23. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001;345:479-86. DOI 10.1056/NEJMoa010273
24. Malone DC, Carter BL, Billups SJ, et al. An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans: the IMPROVE study. Impact of Managed Pharmaceutical Care Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy 2000;20:1149-58. DOI 10.1592/phco.20.15.1149.34590
25. Oliveria SA, Lapeurta P, McCarthy BD, L'Italien GJ, Berlowitz DR, Asch SM. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med 2002;162:413-20. DOI 10.1001/archinte.162.4.413
26. Carter BL, Chrischilles EA, Scholz D, Hayase N, Bell N. Extent of services provided by pharmacists in the Iowa Medicaid Pharmaceutical Case Management program. J Am Pharm Assoc 2003;43:24-33. DOI 10.1331/ 10865800360467015